Salt Lake City, UT (May 25, 2021) 4Life published new research in the Journal of Nutrition & Food Sciences
. The study focuses on FeelRite™
product ingredients and their binding capacities to CB2 receptors in the endocannabinoid system.
Dr. David Vollmer, Chief Scientific Officer: “This publication represents cutting-edge, immune system-focused endocannabinoid system research. The publication shows that non-CBD products can hold their own against top CBD products in the marketplace.”
The publication is another example of 4Life’s ongoing commitment to scientific discovery as a world-leading research manufacturer.
4Life, the Immune System Company™
, and the first to bring transfer factor research to market, has offices in 25 markets to serve the company’s worldwide customers.
For more information:
Vice President Corporate Communications